HBW Insight
With High Profile At FDA, Gottlieb Headed Ambitious Consumer Health Initiatives
By Malcolm Spicer 07 Mar 2019
Scott Gottlieb claimed higher profile than most previous FDA commissioners with frequent Twitter posts and by including his remarks in many agency communications to industries and consumers. In his nearly two years in post, he also had more central role in FDA initiatives in areas such as keeping unsafe products labeled as supplements off the market and explaining why hemp and CBD are available and supplements even though FDA considers the products noncompliant as dietary ingredients.
Request a live demo
How can we help you?
Pharma Report Store